0001209191-19-044456.txt : 20190805
0001209191-19-044456.hdr.sgml : 20190805
20190805143328
ACCESSION NUMBER: 0001209191-19-044456
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190801
FILED AS OF DATE: 20190805
DATE AS OF CHANGE: 20190805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GARVIS WILLIAM GEORGE
CENTRAL INDEX KEY: 0001784345
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28132
FILM NUMBER: 19998313
MAIL ADDRESS:
STREET 1: 1175 PEACHTREE STREET NE
STREET 2: 10TH FLOOR
CITY: ATLANTA
STATE: GA
ZIP: 30361
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STREAMLINE HEALTH SOLUTIONS INC.
CENTRAL INDEX KEY: 0001008586
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
IRS NUMBER: 311455414
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
BUSINESS ADDRESS:
STREET 1: 1230 PEACHTREE STREET NE
STREET 2: SUITE 600
CITY: ATLANTA
STATE: GA
ZIP: 30309
BUSINESS PHONE: 404-446-2052
MAIL ADDRESS:
STREET 1: 1230 PEACHTREE STREET NE
STREET 2: SUITE 600
CITY: ATLANTA
STATE: GA
ZIP: 30309
FORMER COMPANY:
FORMER CONFORMED NAME: STREEAMLINE HEALTH SOLUTIONS INC.
DATE OF NAME CHANGE: 20060809
FORMER COMPANY:
FORMER CONFORMED NAME: LANVISION SYSTEMS INC
DATE OF NAME CHANGE: 19960220
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2019-08-01
0
0001008586
STREAMLINE HEALTH SOLUTIONS INC.
STRM
0001784345
GARVIS WILLIAM GEORGE
1175 PEACHTREE STREET NE, 10TH FLOOR
ATLANTA
GA
30361
0
1
0
0
SVP & COO
Common Stock, $.01 par value
50000
D
Common Stock, $.01 par value
100000
D
Stock Option (right to buy)
1.19
2026-05-22
Common Stock, $0.01 Par Value
50000
D
Stock Option (right to buy)
1.18
2027-03-02
Common Stock, $0.01 Par Value
25000
D
Represents an award of Restricted Stock granted outside the Streamline Health Solutions, Inc. Second Amended and Restated 2013 Stock Incentive Plan to the Reporting Person on August 1, 2019, which vests, assuming continued employment, in four substantially equal installments on November 1, 2019, February 1, 2020, May 1, 2020 and August 1, 2020.
Represents an award of Restricted Stock, which vests, assuming continued employment, in three substantially equal installments: 33% on January 29, 2020, 33% January 29, 2021, and 34% January 29, 2022.
The stock options shall vest and become exercisable in three substantially equal annual installments commencing on May 23, 2017, subject to the provisions in the agreement relating to the effect of termination of employment.
The stock options shall vest and become exercisable in thirty-six substantially equal monthly installments commencing on April 2, 2017, subject to the provisions in the agreement relating to the effect of termination of employment.
/s/ Thomas Gibson, as attorney-in-fact
2019-08-02